Discover how WuXi AppTec's In Vitro ADME team leverages 15+ years of expertise, 200+ experimental models, and advanced technology to transform drug discovery. From permeability and metabolic stability to regulatory-compliant IND support, we strive to turn the 0.1% possibility into a reality.
Related Resources
-
Evaluating Oral Peptides' Gastrointestinal Absorption: Methods and Applications
ArticlesAug 28, 2025Learn More -
Advancing Novel Therapeutics with Innovative DMPK Strategies in Metabolism and Bioanalysis
WebinarsAug 22, 2025Learn More -
Decoding the Key Role of Plasma Protein Binding in Drug-Drug Interactions
ArticlesAug 15, 2025Learn More -
Factsheet- Cytochrome P450 Induction: Relative Induction Score (RIS) Analysis
BrochuresAug 01, 2025Learn More -
More Accurate Prediction of Human Pharmacokinetic Parameters for Small Molecule Compounds: Methods, Models, and Applications
ArticlesAug 01, 2025Learn More -
Antibody-Drug Conjugate (ADC) R&D Innovations and In Vitro ADME Research Considerations
ArticlesJul 24, 2025Learn More -
Development of a High-throughput and Cost-effective Method for Experimental Polar Surface Area Measurement with Ultra-Performance Convergence Chromatography Tandem Mass Spectrometry
PostersJul 24, 2025Learn More -
New Book Release: Drug Metabolism and Pharmacokinetics: Frontiers, Strategies, and Applications | WuXi AppTec DMPK
VideosJul 17, 2025Learn More -
Decoding DMPK Frontiers for Novel Therapeutics: WuXi AppTec DMPK’s New Book Release
BlogsJul 10, 2025Learn More -
ICH M12 Guideline: 4 Key Updates and Reshaping Framework for Enzyme-Mediated Drug-Drug Interaction Studies
ArticlesJun 27, 2025Learn More

Stay Connected
Keep up with the latest news and insights.
Thanks for signing up
Help us get to know you better! By customizing your email preferences, we can deliver curated content relevant to you.
-
Not Now
-
Customize Now